IN8bio publishes Phase 1 glioblastoma trial data in oncology journal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/2/2026

1. NKE
2. USO
3. SPY
4. ACN
5. NVDA
6. FICO
7. TRU
8. TLT
9. LAES
10. WBD

Go back to IN8bio publishes Phase 1 glioblastoma trial data in oncology journal
(NASDAQ: INAB) Delayed: 1.40 --0 (-0%)
Previous Close $1.40    52 Week High $ 
Open $1.42    52 Week Low $ 
Day High $1.46    P/E N/A 
Day Low $1.34    EPS $ 
Volume 39,473